ΕΠΙΠΛΟΚΕΣ ΚΑΙ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΟΥΣ ΜΕΤΑ ΑΠΟ TAVR. · •TAVR...
Transcript of ΕΠΙΠΛΟΚΕΣ ΚΑΙ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΟΥΣ ΜΕΤΑ ΑΠΟ TAVR. · •TAVR...
ΕΠΙΠΛΟΚΕΣ ΚΑΙ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΟΥΣ ΜΕΤΑ ΑΠΟ TAVR.
ΕΙΝΑΙ ΑΝΑΓΚΑΙΟ ΤΟ ΥΒΡΙΔΙΚΟ ΧΕΙΡΟΥΡΓΕΙΟ?
Ματθαίος Παναγιώτου MD FETCSΔιευθυντής καρδιοχειρουργικής
METROPOLITAN HOSPITAL
ΠΑΝΕΛΛΗΝΙΑ ΣΕΜΙΝΑΡΙΑ ΟΜΑΔΩΝ ΕΡΓΑΣΙΑΣ EKE ΘΕΣΣΑΛΟΝΙΚΗ 2017
• TAVR evolved from an experimental procedure to clinical routine
• This has created a strong drive to perform TAVR not only in specialized centers but also in any interventional unit.
RAISED QUESTIONS • Is TAVI similar or better than SAVR in patients at high
risk?
• Is the adoption of TAVI justified for patients at lower surgical risk?
• Do we need a surgical support?
• Is a ‘flying’ surgical team sufficient to cover complications during and after TAVR?
• Is a Hybrid theater necessary ?
HYBRID OPERATING THEATER
A surgical theater that is equipped with advance medical imaging devices such as fived C-arms, ct –scanners , MRI scannersIdeally situated next to other surgical facilities , with a size of 70 square meters to accommodate a team of 8 to 20 people: anesthesiologists ,surgeons, cardiologists,, ,nurses, technicians, perfusionists, support team from device companies etc.
TAVR Procedural complications
• Access –site related complications • Valve embolization ( aortic, left ventricle)• Central valvular aortic regurgitation• Paravalvular aortic regurgitation• Complete heart block• Stroke (Ischemic, hemorrhagic• Coronary occlusion • Annular rupture• Ventricular perforation• Shock , hemodynamic collapse
Access site –related complications
VASCULAR INJURY (1.9-%-34%)
Dissection ,perforation,occlusionProstar failure (7.1%)
CENTRAL VALVULAR AORTIC REGURGITATION
• Prosthesis underexpansion or rupture
• Malfunctioning leaflet damage during crimping or implantation
• Usually self-limited
• Gentle probing of leaflets with a soft wire or catheter
• Delivery of a second TAVR device ( valve-in-valve)
PARAVALVULAR AORTIC REGURGITATION ≥ grade 2(1-47%)
• Post-deployment balloon dilatation
• Repositioning of valve if low (recapture , snare)
• Delivery of a second TAVR device
• Percutaneous vascular closure devises(Amplatzer vascular plug)
• SAVR
ACUTE CORONARY OCCLUSION (0.6-4.1%)
• Low –lying (≤ 10mm) coronary ostia.
• Extensive annular calcification
• Small aortic root ( sinuses of Valsalva of similar or even smaller diameter of aortic annulus)
• PCI ( easier if coronaries already wired before valve implantation)
• CABG
• Complete heart block (2-33%)
– Transvenous pacing with conversion to PPM if neaded
• Annular rupture (0.8-1.3%)
– Reverse anticoagulation
– Surgical repair
– Pericardial drainage
• Stroke ischemic/hemorrhagic (≤ 10%)– Catheter based mechanical embolic
retrieval for large ischemic CVA
– Conservative
• Bleeding /hemorrhage
– Treat sourse if feasible
– Transfusion
– Reversal of anticoagulation
ACUTE MITRAL VALVE INJURY
• In deep implantation-impinging upon mitral curtain
• Uncommon
• Most likely with the TA-TAVI
• Some cases of gradual erosion of the anterior leaflet
VENTRICULAR PERFORATION
• Reverse anticoagulation
• Surgical repair
• Pericardial drainage
VALVE DISLOCATION EMBOLIZATION TO AORTA OR LEFT VENTRICLE (3-11%)
• Recapture or deploy in descending aorta if still attached to delivery system
• Valve in valve
• Endovascular (snare)
• SAVR and extraction
Other TAVI complications
• Acute renal failure requiring renal replacement therapy (1-6%)
• Prosthesis- related endocarditis (0.4-1.1%)
• Transcatheter valve thrombosis (7%)
Sudden and unexplained hypotension during TAVI =
The earliest indication of a major complication
EXCLUDE Retroperitoneal bleeding
Aortic dissection or Aortic annulus –root rupture
Pericardial tamponade
Coronary ostial obstruction
Acute severe aortic regurgitation
Shock-Hemodynamic collapse
• Assess and treat underling cause
• Inotropic support
• Mechanical circulatory support
• CPB
Leipzig Heart Center 7- year single center experience
• 2287 pts : ( 1523 TF, 752 TA, 12 Tao)• Mean age : 84.5±16.3• Fem 84%
• 245 ( 10.7%) required surgical treatment due to major complications
• 42 (1.8%) conversion to full sternotomy• 27 (1.2%) depended on the short –term use of heart- lung machine• 85 ( 3.7%) vascular complications /surgical interventions• 54 ( 2.4%) a thoracotomy within their initial stay• 15 (0.7%) required a cardiac reoperation
Outcome of patients after emergency conversion from TAVR to surgery
• 2 of 8 died in the Hybrid OR• 3 of 8 died in the surgical OR• 6 of 8 died in the catheterization -laboratory
• Hein R et al. Eurointervention 2013;9:446-51
SUGESTIONS- CONCLUSIONS
• Cardiac anesthesiologist
• General anesthesia
• Primed ECC machine for the difficult cases
• Present , active ,experienced and involved cardiac surgery team
• The procedure should be done ideally in a hybrid theater , so the conversion of a TAVI -catastrophe to an emergency surgical procedure can be done immediately